Form N-8A Nuveen Enhanced Strategi
http://archive.fast-edgar.com/20261013/APZZQ22CZM2TUTI2222G2ZZ2EK2BZZ2SVD82
Filed on: October 13, 2026
Form DEFA14A Senti Biosciences Holdin
http://archive.fast-edgar.com/20261013/AQZZP22COZ22BTAP22TE2ZZ2RR43Z22IZ482
Filed on: October 13, 2026
Form 144 Everpure, Inc. Filed by: Singh Ajay
http://archive.fast-edgar.com/20261013/AQ2XH22CZC22G2Z2222B2C4ZKGQMZJF2B282
Filed on: October 13, 2026
Form S-1 EuroSPAC Acquisition
http://archive.fast-edgar.com/20261013/A6ZC922CZ22F22UX222H2CZ2RAHTZZ28Z282
Filed on: October 13, 2026
Form 144 IDT CORP Filed by: SILBERMAN MITCH
http://archive.fast-edgar.com/20261013/AI2N822CZC22L2Z2222C2C4ZPRK9ZJF2B282
Filed on: October 13, 2026
More SEC Filings
View Older Stories-
Form 10-K OKMIN RESOURCES, INC. For: Jun 30
-
Form S-8 Alibaba Group Holding
-
Form 6-K DAQO NEW ENERGY CORP. For: Oct 13
-
Form DEF 14A Marathon Bancorp, Inc. For: Nov 17
-
Form 4 WILLIS TOWERS WATSON For: Oct 09 Filed by: Qureshi Imran Ahmed
-
Form SCHEDULE 13G ArriVent BioPharma, Inc. Filed by: Vivo Opportunity Fund Holdings, L.P.
-
Form 8-K Senti Biosciences Holdin For: Oct 08
-
Form 6-K Nano Labs Ltd For: Oct 13
-
Form 4 QumulusAI, Inc. For: Oct 09 Filed by: Bissell Robert Christopher
-
Form D/A Mojo Ventures Fund I,
-
Form SCHEDULE 13G Knight-Swift Transportat Filed by: PointState Capital LP
-
Form 8-K/A Tarsus Pharmaceuticals, For: Sep 04
-
Form 6-K TOWER SEMICONDUCTOR LTD For: Oct 13
-
Form PRE 14A JOHN HANCOCK VARIABLE For: Jan 05
-
Form 8-K NEPHROS INC For: Oct 13
-
Form 4 Credo Technology Group For: Oct 08 Filed by: Fleming Daniel W.
-
Form DEFA14A Strategy Inc
-
Form 10-K ESCALON MEDICAL CORP For: Jun 30
-
Form 6-K MATERIALISE NV For: Oct 13
-
Form 144 PINTEREST, INC. Filed by: Silbermann Benjamin
-
Form DEF 14A EGAIN Corp For: Dec 04
-
Form 4 CYTOKINETICS INC For: Oct 12 Filed by: Blum Robert I
-
Form 8-K Niki BioSolutions, Inc. For: Oct 13
-
Form FWP ROYAL BANK OF CANADA Filed by: ROYAL BANK OF CANADA
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 4 Strategy Inc For: Oct 08 Filed by: Patten Jarrod M
-
Form 8-A12B Iambic Therapeutics,
-
Form 424B2 HSBC USA INC /MD/
-
Form FWP BARCLAYS BANK PLC Filed by: BARCLAYS BANK PLC
-
Form 424B2 HSBC USA INC /MD/
-
Form 13F-HR 4WEALTH ADVISORS, INC. For: Sep 30
-
Form D Dvant Pharma, Inc.
-
Form D/A Blue Impact Fund II, LP
-
Form 424B2 WELLS FARGO & COMPANY/MN
-
Form 424B2 HSBC USA INC /MD/
-
Form 424B2 HSBC USA INC /MD/
-
Form 424B2 HSBC USA INC /MD/
-
Form 424B2 WELLS FARGO & COMPANY/MN
-
Form D Praxis Tech, Inc.
-
Form F-6 Gunnison Copper Corp./AD Filed by: BANK OF NEW YORK / ADR DIVISION
-
Form 8-K Destra Multi-Alternative For: Oct 13
-
Form 13F-HR GEM Asset Management, For: Sep 30
-
Form 3 Apollo Realty Income For: Sep 30 Filed by: Crouch Hubert
-
Form D MedRhythms, Inc.
-
Form D/A 535 Encore Capital LLC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form D Connelly Capital QP Fund
-
Form D Seven Springs Partners
-
Form 424B2 UBS AG
-
Form 424B3 UBS AG


